Published in Br J Pharmacol on December 01, 1998
Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci U S A (2002) 1.33
Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med (2010) 1.32
Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice. World J Gastroenterol (2006) 1.16
Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal (2011) 1.16
Febrile-range hyperthermia augments pulmonary neutrophil recruitment and amplifies pulmonary oxygen toxicity. Am J Pathol (2003) 1.10
A role for matrix metalloproteinase 9 in IFNγ-mediated injury in developing lungs: relevance to bronchopulmonary dysplasia. Am J Respir Cell Mol Biol (2011) 1.03
Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice. Am J Physiol Lung Cell Mol Physiol (2010) 1.01
Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. Am J Respir Cell Mol Biol (2012) 1.00
Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol (2008) 0.98
Role of nitric oxide in matrix remodeling in diabetes and heart failure. Heart Fail Rev (2003) 0.93
eNOS-beta-actin interaction contributes to increased peroxynitrite formation during hyperoxia in pulmonary artery endothelial cells and mouse lungs. J Biol Chem (2010) 0.86
Improvement of functional recovery of donor heart following cold static storage with doxycycline cardioplegia. Cardiovasc Toxicol (2014) 0.83
Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases. Br J Pharmacol (2004) 0.82
Novel peptide for attenuation of hyperoxia-induced disruption of lung endothelial barrier and pulmonary edema via modulating peroxynitrite formation. J Biol Chem (2014) 0.81
Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator. Nitric Oxide (2014) 0.80
Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis. Int J Exp Pathol (2004) 0.79
Heat Shock Protein 70 Prevents Hyperoxia-Induced Disruption of Lung Endothelial Barrier via Caspase-Dependent and AIF-Dependent Pathways. PLoS One (2015) 0.77
Nitric oxide and hyperoxic acute lung injury. Med Gas Res (2016) 0.75
Profilin-1 promotes the development of hypertension-induced artery remodeling. J Histochem Cytochem (2014) 0.75
Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling. PLoS One (2017) 0.75
Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol (1988) 4.16
Ecology. Giant pandas in a changing landscape. Science (2001) 2.73
Nitric oxide synthase activities in human myocardium. Lancet (1993) 2.72
cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A (1996) 2.17
Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol (1990) 2.12
Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation (2000) 2.01
Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol (2007) 1.88
Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res (1999) 1.78
The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med (2000) 1.68
Release of gelatinase A during platelet activation mediates aggregation. Nature (1997) 1.65
Secondary preventive medication persistence and adherence 1 year after stroke. Neurology (2011) 1.62
Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Thorac Cardiovasc Surg (2001) 1.55
Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A (1994) 1.53
Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost (1999) 1.43
Impact of pregnancy-induced hypertension on fetal growth. Am J Obstet Gynecol (1999) 1.41
Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med (1993) 1.40
Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer (1994) 1.39
Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci U S A (1994) 1.29
Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res (1994) 1.28
Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet (1994) 1.20
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res (2000) 1.19
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res (2001) 1.18
Frequency of resistance to Bacillus thuringiensis toxin Cry1Ab in an Iowa population of European corn borer (Lepidoptera: Crambidae). J Econ Entomol (2000) 1.17
Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun (1993) 1.15
Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol (1997) 1.15
The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol (1995) 1.14
Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost (1998) 1.07
Sleep deprivation and the effect on exercise performance. Sports Med (1989) 1.00
Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells. Can J Physiol Pharmacol (1999) 0.99
Effect of melarsoprol treatment on circulating IL-10 and TNF-alpha levels in human African trypanosomiasis. Clin Immunol Immunopathol (1997) 0.98
Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol Reprod (2000) 0.95
Sub-clinical necrotic enteritis in broiler chickens: novel etiological consideration based on ultra-structural and molecular changes in the intestinal tissue. Res Vet Sci (2008) 0.94
Nitric oxide activates chloride currents in human lung epithelial cells. Am J Physiol (1997) 0.94
Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand (2003) 0.93
Response of lipoprotein lipase in various tissues to cold exposure. Am J Physiol (1971) 0.93
Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br J Pharmacol (2007) 0.92
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap. Br J Pharmacol (2011) 0.92
Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor. Placenta (2005) 0.92
Contribution of exertional hyperthermia to sympathoadrenal-mediated lymphocyte subset redistribution. J Appl Physiol (1985) (1999) 0.91
Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes. J Immunol (1985) 0.91
Forest conservation in the Congo Basin. Science (2003) 0.91
Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br J Pharmacol (1994) 0.91
The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther (1998) 0.91
Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin. Br J Pharmacol (2001) 0.91
Villous trophoblasts cultured on semi-permeable membranes form an effective barrier to the passage of high and low molecular weight particles. Placenta (2001) 0.90
Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Br J Pharmacol (2001) 0.90
Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance. Br J Pharmacol (2012) 0.89
Differential effects of maternal nutrient restriction through pregnancy on kidney development and later blood pressure control in the resulting offspring. Am J Physiol Regul Integr Comp Physiol (2008) 0.89
Strenuous exercise and immunological changes: a multiple-time-point analysis of leukocyte subsets, CD4/CD8 ratio, immunoglobulin production and NK cell response. Int J Sports Med (1995) 0.89
Prostaglandin endoperoxide H synthase (PGHS) activity and PGHS-1 and -2 messenger ribonucleic acid abundance in human chorion throughout gestation and with preterm labor. J Clin Endocrinol Metab (1998) 0.88
Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet (1998) 0.88
Expression of myometrial activation and stimulation genes in a mouse model of preterm labor: myometrial activation, stimulation, and preterm labor. Endocrinology (2000) 0.88
Prostaglandin H synthase-2 expression increases in human gestational tissues with spontaneous labour onset. Reprod Fertil Dev (1995) 0.88
Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther (1992) 0.87
Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes. Am J Physiol Lung Cell Mol Physiol (2001) 0.87
Development of "sports anemia" in physically fit men after daily sustained submaximal exercise. Aviat Space Environ Med (1980) 0.87
Impact of maternal undernutrition and fetal number on glucocorticoid, growth hormone and insulin-like growth factor receptor mRNA abundance in the ovine fetal kidney. Reproduction (2005) 0.87
Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Med Sci Monit (2001) 0.86
Inheritance of host finding ability on structurally complex surfaces. Oecologia (2003) 0.86
Induction of nitric oxide release by interferon-gamma inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J Pharmacol Exp Ther (1994) 0.86
Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. J Clin Endocrinol Metab (1995) 0.86
Endurance exercise with and without a thermal clamp: effects on leukocytes and leukocyte subsets. J Appl Physiol (1985) (1996) 0.86
Nitric oxide and the pathogenesis of heart muscle disease. Eur J Clin Invest (1995) 0.85
Cytokine induction during exertional hyperthermia is abolished by core temperature clamping: neuroendocrine regulatory mechanisms. Int J Hyperthermia (2004) 0.85
Maternal smoking and preeclampsia. J Reprod Med (2000) 0.85
Estradiol-17 beta and 2-hydroxyestradiol-17 beta-induced differential production of prostaglandins by cells dispersed from human intrauterine tissues at parturition. Prostaglandins (1983) 0.85
Decidual activation: abundance and localization of prostaglandin F2alpha receptor (FP) mRNA and protein and uterine activation proteins in human decidua at preterm birth and term birth. Placenta (2006) 0.85
Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med (1996) 0.84
Prostaglandin-endoperoxide H synthase-2 expression and activity increases with term labor in human chorion. Am J Physiol (1997) 0.84
Prostanoid concentrations in maternal/fetal plasma and amniotic fluid and intrauterine tissue prostanoid output in relation to myometrial contractility during the onset of adrenocorticotropin-induced preterm labor in sheep. Endocrinology (1985) 0.84
Development of receptors for leukotriene B4 on HL-60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. J Immunol (1986) 0.84
Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase. Br J Pharmacol (1993) 0.84
A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury. Anaesth Intensive Care (2012) 0.83
Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance. Can J Physiol Pharmacol (1998) 0.83
Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J (1995) 0.83
Regulation of prostaglandin H2 synthase-2 expression in primary human amnion cells by tyrosine kinase dependent mechanisms. Biochim Biophys Acta (1998) 0.83
Changes in the hemostatic system and in blood and urine chemistry of human subjects following decompression from a hyperbaric environment. Aerosp Med (1972) 0.82
Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism. J Clin Endocrinol Metab (1988) 0.82
Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells. Endocrinology (1995) 0.82
Cyclic intramuscular temperature fluctuations in the human forearm during cold-water immersion. Eur J Appl Physiol Occup Physiol (1991) 0.82
Nitric oxide in the clinical arena. J Hypertens (1994) 0.82
Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis. J Thromb Haemost (2006) 0.82
Dive-induced modifications in platelet kinetics in rats. Undersea Biomed Res (1977) 0.82
Prostaglandin output in relation to parturition by cells dispersed from human intrauterine tissues. J Clin Endocrinol Metab (1983) 0.82
Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol (2000) 0.82
An ultrastructural study of stored human platelets after washing using prostacyclin. Br J Haematol (1985) 0.81
Effect of lithium on acute oxygen toxicity and associated changes in brain gamma-aminobutyric acid. Aerosp Med (1973) 0.81
The ion selective function of the epithelium of the membranous canal walls. Acta Otolaryngol (1968) 0.81
Prostaglandin endoperoxide H synthase mRNA expression in the human amnion and decidua during pregnancy and in the amnion at preterm labour. Mol Hum Reprod (1999) 0.81
Sleep and stress in man: an approach through exercise and exposure to extreme environments. Can J Physiol Pharmacol (1998) 0.80
[Cystatins]. Postepy Biochem (1987) 0.80
Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor. J Clin Endocrinol Metab (1994) 0.80
Rapid release of matrix metalloproteinase (MMP)-2 by thrombin in the rat aorta: modulation by protein tyrosine kinase/phosphatase. Thromb Haemost (1999) 0.80